🔎 Trials Near Me

Akèy › Maladi Alzheimer › New Jersey › Toms River

Etid klinik pou Maladi Alzheimer nan Toms River, NJ

9 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan ak bò kote Toms River (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

Ap rekriteFaz 2
  • Bio Behavioral Health, Toms River
Laj 55 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06540833

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Ap rekriteFaz 3
  • Advanced Memory Research Institute - CenExel - PPDS, Toms River
Laj 55 a 90 · Tout sèks · Mizajou Sep 22, 2026 · NCT06585787

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

Ap rekriteFaz 2
  • CenExel Research - Toms River, Toms River
Laj 55 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06847321

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

Ap rekriteFaz 3
  • Local Institution - 2650, Toms River
Laj 55 a 90 · Tout sèks · Mizajou Sep 16, 2026 · NCT07011745

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Ap rekriteFaz 2
  • Local Institution - 0081, Toms River
Laj 55 a 90 · Tout sèks · Mizajou Sep 1, 2026 · NCT06808984

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

Ap rekriteFaz 2
  • CenExel- AMRI ( Site 1018), Toms River
Laj 50 a 85 · Tout sèks · Mizajou Aug 26, 2026 · NCT07033494

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

Ap rekriteFaz 1
  • CenExel AMRI, Toms River
Laj 50 a 85 · Tout sèks · Mizajou Aug 24, 2026 · NCT06297590

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

Ap rekriteFaz 3
  • Advanced Memory Research Institute of New Jersey, Toms River
Laj 60 a 85 · Tout sèks · Mizajou Aug 20, 2026 · NCT06976216

Open-label Extension Study in Participants With Early Alzheimer's Disease

Ap rekriteFaz 2
  • GSK Investigational Site, Toms River
Laj 50 a 85 · Tout sèks · Mizajou Feb 2, 2026 · NCT07105709

Etid Maladi Alzheimer nan lòt vil

Lòt etid nan Toms River

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.